The for rats is 5620 mg/kg, indicating low acute toxicity. Given that the chemical is naturally present in many organisms, there is little risk of toxicity.
World Health Organization (WHO) has assessed the
Acceptable Daily Intake (ADI) of ethyl acetate at 25 mg per kg of body weight. This is similar to the ADI of other artificial
sweeteners that are friendly and have been commonly used for a long time. According to
European Food Safety Authority (EFSA), ethyl acetate taken orally is rapidly metabolized and broken down. The half-life in blood after ingestion exposure is known to be approximately 35 seconds. Overexposure to ethyl acetate may cause
irritation of the eyes, nose, and throat. Severe overexposure may cause weakness, drowsiness, and unconsciousness. Humans exposed to a concentration of 400 ppm in 1.4 mg/L ethyl acetate for a short time were affected by nose and throat irritation. Ethyl acetate is an irritant of the
conjunctiva and
mucous membrane of the
respiratory tract. Animal experiments have shown that, at very high concentrations, the ester has
central nervous system depressant and lethal effects; at concentrations of 20,000 to 43,000 ppm (2.0–4.3%), there may be
pulmonary edema with
hemorrhages, symptoms of central nervous system depression, secondary
anemia and
liver damage. In humans, concentrations of 400 ppm cause irritation of the nose and
pharynx; cases have also been known of irritation of the conjunctiva with temporary opacity of the
cornea. In rare cases exposure may cause
sensitization of the mucous membrane and
eruptions of the skin. The irritant effect of ethyl acetate is weaker than that of
propyl acetate or
butyl acetate. ==References==